Cargando…
VASP Increases Hepatic Fatty Acid Oxidation by Activating AMPK in Mice
Activation of AMP-activated protein kinase (AMPK) signaling reduces hepatic steatosis and hepatic insulin resistance; however, its regulatory mechanisms are not fully understood. In this study, we sought to determine whether vasodilator-stimulated phosphoprotein (VASP) signaling improves lipid metab...
Autores principales: | Tateya, Sanshiro, Rizzo-De Leon, Norma, Handa, Priya, Cheng, Andrew M., Morgan-Stevenson, Vicki, Ogimoto, Kayoko, Kanter, Jenny E., Bornfeldt, Karin E., Daum, Guenter, Clowes, Alexander W., Chait, Alan, Kim, Francis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661609/ https://www.ncbi.nlm.nih.gov/pubmed/23349495 http://dx.doi.org/10.2337/db12-0325 |
Ejemplares similares
-
Endothelial NO/cGMP/VASP Signaling Attenuates Kupffer Cell Activation and Hepatic Insulin Resistance Induced by High-Fat Feeding
por: Tateya, Sanshiro, et al.
Publicado: (2011) -
The role of vasodilator-stimulated phosphoprotein (VASP) in the control of hepatic gluconeogenic gene expression
por: Tateya, Sanshiro, et al.
Publicado: (2019) -
M2 Macrophage Polarization Mediates Anti-inflammatory Effects of Endothelial Nitric Oxide Signaling
por: Lee, Woo Je, et al.
Publicado: (2015) -
Apolipoprotein A-I Attenuates Palmitate-Mediated NF-κB Activation by Reducing Toll-Like Receptor-4 Recruitment into Lipid Rafts
por: Cheng, Andrew M., et al.
Publicado: (2012) -
Apolipoprotein C3 and apolipoprotein B colocalize in proximity to macrophages in atherosclerotic lesions in diabetes
por: Kanter, Jenny E., et al.
Publicado: (2020)